1. Adverse Effect of Antithrombotic Medications on Bleeding Events and Comparison of Antithrombotic Agents in Hemodialysis Patients. Issue 1 (8th August 2018) Authors: Daimon, Shoichiro Journal: Therapeutic apheresis and dialysis Issue: Volume 23:Issue 1(2019) Page Start: 32 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Comparison of the Effect of the Same Dose of a 4‐Weekly Continuous Erythropoietin Receptor Activator Administered Once Every 2 or 4 Weeks in Hemodialysis Patients. Issue 5 (10th September 2014) Authors: Daimon, Shoichiro Journal: Therapeutic apheresis and dialysis Issue: Volume 18:Issue 5(2014) Page Start: 518 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Effect of oral and intravenous iron therapy on hemoglobin levels in hemodialysis patients according to serum ferritin level. Issue 1 (December 2016) Authors: Daimon, Shoichiro; Mizushima, Ichiro Journal: Renal replacement therapy Issue: Volume 2:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Effect of sacubitril–valsartan on cardiac function in hemodialysis patients. Issue 1 (10th August 2021) Authors: Daimon, Shoichiro; Yasuda, Miyuki; Maeda, Kazumasa Journal: Therapeutic apheresis and dialysis Issue: Volume 26:Issue 1(2022) Page Start: 244 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Efficacy for Anemia and Changes in Serum Ferritin Levels by Long‐Term Oral Iron Administration in Hemodialysis Patients. Issue 5 (13th March 2019) Authors: Daimon, Shoichiro Journal: Therapeutic apheresis and dialysis Issue: Volume 23:Issue 5(2019) Page Start: 444 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Efficacy of Coronary Artery Screening Tests and Intervention in Hemodialysis Patients. Issue 5 (27th March 2014) Authors: Daimon, Shoichiro; Mizushima, Ichiro; Hamano, Ryoko; Terai, Hidenobu Journal: Therapeutic apheresis and dialysis Issue: Volume 18:Issue 5(2014) Page Start: 443 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Influence of continuous erythropoietin receptor activator (CERA) administration intervals on erythropoietic effect in hemodialysis patients. Issue 1 (December 2016) Authors: Daimon, Shoichiro; Nuka, Hiromi; Kitada, Kinya; Suzuki, Yasunori; Kim, Fae; Kawano, Mitsuhiro Journal: Renal replacement therapy Issue: Volume 2:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Possible role of neocytolysis in anemia in hemodialysis patients with darbepoetin alfa or continuous erythropoietin receptor activator. Issue 5 (28th July 2020) Authors: Daimon, Shoichiro Journal: Therapeutic apheresis and dialysis Issue: Volume 24:Issue 5(2020) Page Start: 602 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Serum carnitine concentration and the acyl to free carnitine ratio in nondialysis chronic kidney disease and hemodialysis patients. Issue 1 (31st March 2021) Authors: Daimon, Shoichiro; Yasuda, Miyuki; Nishitani, Mitsuhiro Journal: Therapeutic apheresis and dialysis Issue: Volume 26:Issue 1(2022) Page Start: 122 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Shortened red cell life span as a factor of anemia of mild inflammation in hemodialysis patients. Issue 6 (3rd March 2020) Authors: Daimon, Shoichiro Journal: Therapeutic apheresis and dialysis Issue: Volume 24:Issue 6(2020) Page Start: 742 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗